Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0002871 (
anemia
)
52,094
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
It has been shown by genetic complementation analysis that a mitomycin C-sensitive mutant (V-H4) of Chinese hamster V79 cells is the first rodent equivalent of Fanconi
anemia
(FA) group A. The V-H4 mutant shows many typical characteristics of cells derived from FA patients. V-H4 cells exhibit increased sensitivity towards cross-linking agents as MMC (approximately 30-fold), cis-DDP (approximately 10-fold), DEB (approximately 10-fold), and PUVA (approximately 1.6-fold), but an only slightly increased sensitivity to monofunctional alkylating agents (EMS and MMS) and actinomycin D. V-H4 cells are also moderately sensitive to adriamycin (1.6-fold), and not sensitive to H2O2. The levels of chromosomal aberrations induced by MMC and cis-DDP treatment are higher (4- to 6-fold) in V-H4 cells than in the wild-type V79 cells. Genetic complementation analysis with other Chinese hamster mutants hypersensitive to MMC (irs1, irs1SF,
UV20
and UV41) indicates clearly that V-H4 belongs to a different, new complementation group. This unique mutant is very stable and can serve as a vehicle to isolate the complementing FA-A gene from normal human DNA.
...
PMID:The Chinese hamster V79 cell mutant V-H4 is phenotypically like Fanconi anemia cells. 226 31
Three Mitomycin C (MMC)-hypersensitive mutants (CL-V1B, CL-V5B, and CL-V101B) were isolated from Chinese hamster V79B cells by the replica plating technique. In comparison to the parental cell line, CL-V1B, CL-V5B, and CL-V101B show about a 22-, 32-, and 13-fold increased sensitivity to MMC, respectively (judged by the D10). These mutants are also sensitive to other DNA cross-linking agents, such as 1,2,3,4-diepoxybutane (9-, 19-, and 12-fold, respectively) and cis-diamminedichloroplatinum(II) (17-, 12-, and 6-fold, respectively). CL-V5B and CL-V101B display an exclusive sensitivity to DNA cross-linking agents, whereas CL-V1B also shows an increased sensitivity to monofunctional alkylating agents, such as methyl methanesulfonate (3-fold) and ethyl methanesulfonate (2-fold), and UV254mm (2-fold). Approximately 2-3-fold higher levels of spontaneous chromosomal aberrations are found in these three mutants in comparison to wild-type V79B cells. At a MMC survival level of 80%, CL-V5B demonstrates a 16-fold higher level of MMC-induced chromosomal damage than V79B. Despite phenotypical heterogeneity within this group of mutants, hybrid clones derived after fusion remained MMC sensitive, indicating that these mutants belong to the same complementation group. To determine whether the mutants represent a new complementation group among other Chinese hamster cell mutants that also display hypersensitivity to MMC, CL-V1B cells were fused with mutants representing different complementation groups i.e., irs1, irs3, irs1SF,
UV20
, UV41, V-H4, and V-C8 cells. In all cases, the derived hybrids regained MMC sensitivity similar to wild-type cells, indicating that the CL-V1B mutant represents a new complementation group. The phenotype of CL-V1B, CL-V5B, and CL-V101B cells closely resembles the phenotype of Fanconi
anemia
cells, suggesting that these hamster mutants could be defective in a gene that is involved in this disorder.
...
PMID:A new complementation group of mitomycin C-hypersensitive Chinese hamster cell mutants that closely resembles the phenotype of fanconi anemia cells. 761 81